Clinical trial
A PHASE I STUDY OF DEPSIPEPTIDE (NSC#630176, IND# 51810) IN PEDIATRIC PATIENTS WITH REFRACTORY SOLID TUMORS AND LEUKEMIAS
NCT00053963 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A PHASE I STUDY OF DEPSIPEPTIDE (NSC#630176, IND# 51810) IN PEDIATRIC PATIENTS WITH REFRACTORY SOLID TUMORS AND LEUKEMIAS
- Lead sponsor
- National Cancer Institute (NCI)
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- September 30, 2002
- Completion date
- Not reported
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
blastic phase chronic myelogenous leukemia, childhood central nervous system germ cell tumor, childhood choroid plexus tumor, childhood chronic myelogenous leukemia, childhood craniopharyngioma, childhood grade i meningioma, childhood grade ii meningioma, childhood grade iii meningioma, childhood high-grade cerebral astrocytoma, childhood infratentorial ependymoma, childhood low-grade cerebral astrocytoma, childhood spinal cord neoplasm, childhood supratentorial ependymoma, recurrent childhood acute lymphoblastic leukemia, recurrent childhood acute myeloid leukemia, recurrent childhood brain stem glioma, recurrent childhood cerebellar astrocytoma, recurrent childhood cerebral astrocytoma, recurrent childhood ependymoma, recurrent childhood medulloblastoma, recurrent childhood supratentorial primitive neuroectodermal tumor, recurrent childhood visual pathway and hypothalamic glioma, refractory chronic lymphocytic leukemia, relapsing chronic myelogenous leukemia, unspecified childhood solid tumor, protocol specific